| Date | Time | Source | Headline | Symbol | Company |
| 04/13/2012 | 4:44PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/13/2012 | 4:44PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/12/2012 | 4:47PM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/12/2012 | 6:09AM | Edgar (US Regulatory) | Proxy Statement (definitive) (DEF 14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/09/2012 | 5:03PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/09/2012 | 1:08PM | Dow Jones News | Icahn Files Lawsuit Against Amylin To Force Nomination Extension | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/09/2012 | 11:00AM | Zacks | Amylin Completes BLA Submission - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/04/2012 | 4:19PM | Dow Jones News | 2nd UPDATE: Icahn Tells Amylin To Pursue Sale, Seeks Proxy Extension | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/04/2012 | 10:13AM | Dow Jones News | UPDATE: Icahn Tells Amylin To Pursue Sale, Seeks Proxy Extension | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/04/2012 | 9:42AM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/03/2012 | 8:00AM | PR Newswire (US) | Amylin Completes Biologics License Application for Metreleptin to Treat Diabetes and/or Hypertriglyceridemia in Patients With... | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/30/2012 | 8:20AM | Marketwired | Amylin Pharmaceuticals, Inc. and Illumina, Inc. Benefit From JOBS Act | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/30/2012 | 4:30AM | Zacks | The Zacks Analyst Blog Highlights: Amylin Pharmaceutical, Bristol-Myers Squibb, Eli Lilly, Express Scripts & Medco Health Sol.. | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/29/2012 | 7:19PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/29/2012 | 11:15AM | Zacks | Amylin Shoots Up on Takeover Rumors - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/29/2012 | 5:06AM | Zacks | Company News for March 29, 2012 - Corporate Summary | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/28/2012 | 10:21AM | Dow Jones News | UPDATE: Amylin Has Rejected $3.5 Billion Buyout Bid By Bristol-Myers -Bloomberg | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/28/2012 | 10:08AM | Dow Jones News | Amylin Has Rejected $3.5 Billion Buyout Bid By Bristol-Myers -Bloomberg | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/26/2012 | 11:00AM | Zacks | EU Label Expansion for Amylin Drug - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/23/2012 | 12:06PM | GlobeNewswire Inc. | Amylin Pharmaceuticals, Inc. [AMLN] to Ring The NASDAQ Stock Market Opening Bell | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/23/2012 | 9:08AM | Dow Jones News | Amylin: EU Approves Diabetes Treatment Byetta With Basal Insulin | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/23/2012 | 8:00AM | PR Newswire (US) | BYETTA® Approved for Use with Basal Insulin in Europe | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/09/2012 | 5:28PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/09/2012 | 5:27PM | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(5) (424B5) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/08/2012 | 9:01AM | PR Newswire (US) | Amylin Pharmaceuticals Announces Pricing of Public Offering of Common Stock | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/08/2012 | 8:00AM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Barclays Capital Global Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/07/2012 | 6:13PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/07/2012 | 6:13PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/07/2012 | 6:13PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/07/2012 | 6:13PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |